title: [A clinical review of pleurodesis for patients with poor performance status].
abstract: BACKGROUND
  Although pleurodesis is an effective treatment for malignant pleural effusion, we hesitate to use in patients with poor performance status (PS) because of its side effects.
  
  
  METHODS
  Of 46 pleurodesis cases in our institution between 2006 and 2010, 24 poor PS cases (>3) were classified into 2 groups according to survival (beyond 3 months) or non-survival, and 3 groups according to condition: PS improved after pleurodesis, remained stable, or was exacerbated and we analyzed their backgrounds.
  
  
  RESULTS
  Among the 24 cases (66.7%), there were 5 and 19 survival and non-survival cases. Patient backgrounds, characteristics of the lesions and examination results did not differ significantly among them. On the other hand, the ratio of successful initial pleurodesis in the exacerbated PS group was lower than in the improved and stable groups (16.7% vs. 100%, 87.5%). The 1- and 3-month survival rates of unsuccessful cases were lower than those of successful cases (33.3% vs. 77.8%, 0% vs. 32.4%).
  
  
  CONCLUSIONS
  Success of initial pleurodesis can affect PS and outcome, thus it is important to improve the number of successful cases of initial pleurodesis.
authors: Department of Pulmonology, Kameda Medical Center.
authors: Katsutoshi
authors: K
authors: Ando
authors: Yoshihiro
authors: Y
authors: Ohkuni
authors: Hideki
authors: H
authors: Makino
authors: Akina
authors: A
authors: Komatsu
authors: Ryo
authors: R
authors: Matsunuma
authors: Kei
authors: K
authors: Nakashima
authors: Nobuhiro
authors: N
authors: Asai
authors: Norihiro
authors: N
authors: Kaneko
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D016066:Pleural Effusion, Malignant / Q000628:therapy*; D018700:Pleurodesis / Q000009:adverse effects* / Q000401:mortality; D012189:Retrospective Studies; D016896:Treatment Outcome